| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 213.94B | 230.53B | 208.37B | 198.55B | 177.83B | 133.00B |
| Gross Profit | 22.16B | 22.07B | 21.41B | 23.30B | 19.70B | 14.41B |
| EBITDA | 15.71B | 16.57B | 14.34B | 16.79B | 13.87B | 10.37B |
| Net Income | 8.06B | 7.45B | 7.28B | 9.12B | 7.78B | 6.13B |
Balance Sheet | ||||||
| Total Assets | 143.99B | 155.66B | 138.44B | 134.59B | 112.03B | 85.91B |
| Cash, Cash Equivalents and Short-Term Investments | 42.40B | 20.22B | 41.40B | 46.16B | 32.85B | 29.68B |
| Total Debt | 44.38B | 54.12B | 43.85B | 41.79B | 42.45B | 31.86B |
| Total Liabilities | 82.01B | 90.29B | 78.00B | 77.05B | 73.86B | 56.17B |
| Stockholders Equity | 59.30B | 62.39B | 57.78B | 55.12B | 35.92B | 28.95B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -14.48B | 185.00M | 5.75B | 2.58B | 5.25B |
| Operating Cash Flow | 0.00 | 13.36B | 8.90B | 10.80B | 11.41B | 6.09B |
| Investing Cash Flow | 0.00 | -39.17B | -10.61B | -5.86B | -14.02B | -5.24B |
| Financing Cash Flow | 0.00 | 4.65B | -3.04B | 8.58B | 5.53B | 799.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
78 Outperform | ¥193.23B | 5.05 | ― | 1.84% | 18.74% | 223.25% | |
70 Outperform | ¥144.51B | 10.77 | ― | 3.65% | 3.06% | 1.48% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
62 Neutral | ¥307.18B | 26.94 | ― | 1.28% | 6.67% | 10.43% | |
59 Neutral | ¥111.00B | 16.00 | ― | 3.21% | 10.64% | 2.29% | |
59 Neutral | ¥334.63B | 18.56 | 8.30% | 2.50% | 5.27% | -5.79% | |
59 Neutral | ¥297.34B | 17.48 | ― | 2.94% | 1.47% | -10.54% |